PART 11: The Impact of COVID-19 on Oncology Research: Immediate and Long-term Effects

May 28, 2020
Previous Video
PART 12: Public Awareness of Clinical Research and the Path To Diversity in Clinical Trials
PART 12: Public Awareness of Clinical Research and the Path To Diversity in Clinical Trials

Next Video
PART 10: Unique Challenges and Opportunities for Emerging Biopharma Companies with Focused Pipelines
PART 10: Unique Challenges and Opportunities for Emerging Biopharma Companies with Focused Pipelines